Synchron

Synchron is a neurotechnology company that specializes in brain-computer interface (BCI) devices aimed at restoring control of digital devices for individuals with severe motor impairments. Their key innovation, the Stentrode, is a minimally invasive implant that is inserted via blood vessels. This device detects brain signals related to motor intent and converts them into digital commands, allowing users to interact with technology using only their thoughts. The Stentrode implant works in conjunction with a BCI system that translates neural signals into commands for digital devices. This technology enables users to perform tasks such as texting, scheduling, and controlling smart home devices without physical or voice input. Synchron has achieved integration with major consumer technologies, including Apple devices and Amazon Alexa, enhancing the user experience for those with disabilities. Their platform supports patients by providing seamless interaction with digital ecosystems, ultimately improving independence and quality of life.

• Employees130
• Founded2016
• Annual Revenue$144500000
• Total Funding$125990000